0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessSC natalizumab administration will consistently reduce consumption of patient and HCP times per procedure and associated costs.
Massimo Filippi, Luigi Grimaldi, Antonella Conte, Rocco Totaro, Maria Rosaria Valente, Simona Malucchi, Franco Granella, Cinzia Cordioli, Vincenzo Brescia Morra, Chiara Zanetta, Daria Perini, Laura Santoni, Vanessa Ziccone, R. Garba, A. Motta, S. Albanesi, O. Oddo, A. Impagliato, Gina Ferrazzano, V. Di Rosa, Maria Carmela Tartaglia, Anna Di Vito, Alfredo R. Galassi, Roberto Prota, Roberto Garbo, Ilaria Del Negro, L. Nesi, Marco Capobianco, Elena Tsantes, R. Agosta, A. M. Valleri, L. Galuppini, Santa Mascara, F. Bertocchi, Emanuela Chiarini, Marcello Moccia, Giorgia Puorro (2023). Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study. , 271(1), DOI: https://doi.org/10.1007/s00415-023-11955-0.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2023
Authors
37
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1007/s00415-023-11955-0
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
